We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+29.29%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$9.47B
AUM Growth
+$451M
Cap. Flow
+$1.13B
Cap. Flow %
11.96%
Top 10 Hldgs %
21.59%
Holding
903
New
107
Increased
255
Reduced
393
Closed
103

Top Buys

Rank Stock Value
1
BPMC
Blueprint Medicines
BPMC
+$51.9M
2
MRK icon
Merck
MRK
+$50.9M
3
DHR icon
Danaher
DHR
+$45.3M
4
TMO icon
Thermo Fisher Scientific
TMO
+$37.8M
5
JD icon
JD.com
JD
+$37.7M

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$103M
2
BABA icon
Alibaba
BABA
+$98.6M
3
CRM icon
Salesforce
CRM
+$62.5M
4
BMY icon
Bristol-Myers Squibb
BMY
+$59.4M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$48.6M

Sector Composition

Rank Sector Weight
1 Healthcare 34.61%
2 Technology 20.94%
3 Consumer Discretionary 8.9%
4 Financials 8.59%
5 Communication Services 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NTRS icon
526
Northern Trust
NTRS
$22.2B
$1.4M 0.01%
17,651
-2,353
-12% -$187K
HRL icon
527
Hormel Foods
HRL
$14.1B
$1.39M 0.01%
28,707
-7,782
-21% -$372K
WTRG icon
528
Essential Utilities
WTRG
$11.5B
$1.39M 0.01%
+32,817
New +$1.39M
BN icon
529
Brookfield
BN
$104B
$1.37M 0.01%
79,461
+1,506
+2% +$26.5K
SHOP icon
530
Shopify
SHOP
$169B
$1.34M 0.01%
14,160
+920
+7% +$63.9K
IEX icon
531
IDEX
IEX
$16.6B
$1.33M 0.01%
8,447
-3,702
-30% -$566K
HPE icon
532
Hewlett Packard
HPE
$60.4B
$1.33M 0.01%
+136,735
New +$1.34M
O icon
533
Realty Income
O
$61.3B
$1.31M 0.01%
22,742
-4,371
-16% -$233K
NUE icon
534
Nucor
NUE
$60.5B
$1.31M 0.01%
31,617
-4,472
-12% -$181K
HES
535
DELISTED
Hess
HES
$1.3M 0.01%
25,158
-253,235
-91% -$11.6M
UGI icon
536
UGI
UGI
$7.92B
$1.3M 0.01%
40,916
-71,063
-63% -$2.16M
MTB icon
537
M&T Bank
MTB
$36.6B
$1.29M 0.01%
12,375
-2,781
-18% -$294K
SYF icon
538
Synchrony
SYF
$25.1B
$1.27M 0.01%
57,422
-184,270
-76% -$3.59M
ANGO icon
539
AngioDynamics
ANGO
$593M
$1.27M 0.01%
125,000
+55,000
+79% +$567K
EFX icon
540
Equifax
EFX
$22B
$1.26M 0.01%
7,348
-4,631
-39% -$686K
CSGP icon
541
CoStar Group
CSGP
$12.4B
$1.26M 0.01%
17,740
-7,610
-30% -$492K
CARR icon
542
Carrier Global
CARR
$52.5B
$1.26M 0.01%
+56,714
New +$1.05M
VTR icon
543
Ventas
VTR
$47.7B
$1.26M 0.01%
34,374
-7,474
-18% -$247K
ENB icon
544
Enbridge
ENB
$121B
$1.25M 0.01%
41,092
+3,660
+10% +$112K
BLFS icon
545
BioLife Solutions
BLFS
$1.56B
$1.24M 0.01%
76,000
– –
RNG icon
546
RingCentral
RNG
$4.77B
$1.24M 0.01%
+4,352
New +$1.1M
CMA
547
DELISTED
Comerica
CMA
$1.24M 0.01%
32,527
-26,237
-45% -$915K
PXD
548
DELISTED
Pioneer Natural Resource Co.
PXD
$1.23M 0.01%
12,635
-833
-6% -$73.4K
PARA
549
DELISTED
Paramount Global Class B
PARA
$1.23M 0.01%
52,816
-169,078
-76% -$3.26M
DOC icon
550
Healthpeak Properties
DOC
$15.7B
$1.23M 0.01%
44,568
-5,856
-12% -$149K
20 21
22
23 24

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q2 2020 Portfolio in Review

As of Q2 2020, Candriam SCA held 903 positions worth $9.47B, up 5% from $9.02B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA deployed $1.13B of net new capital in Q2 2020, opening 107 new positions and adding to 255 existing holdings. Its largest new stake was JD.com: 744,410 shares worth $44.8M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 31% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $103M trimmed.

  • Candriam SCA's largest Q2 2020 buy was JD.com: 744,410 shares worth $44.8M.
  • Candriam SCA added most to Blueprint Medicines in Q2 2020, an estimated $51.9M increase.
  • Candriam SCA's biggest Q2 2020 reduction was Regeneron Pharmaceuticals, cutting an estimated $103M.
  • Candriam SCA fully exited Salesforce in Q2 2020, selling an estimated $62.5M.
  • Candriam SCA's ten largest holdings make up 22% of its $9.47B portfolio in Q2 2020.
  • Candriam SCA opened 107 new positions and closed 103 in Q2 2020.
  • Candriam SCA's portfolio value rose 5% quarter-over-quarter to $9.47B.

Based on Candriam SCA's 13F filing for Q2 2020, filed 23 Jul 2020.